Etanercept treatment of psoriatic arthritis: safety, efficacy, and effect on disease progression
PJ Mease, AJ Kivitz, FX Burch, EL Siegel… - … : Official Journal of …, 2004 - Wiley Online Library
Objective Etanercept has been shown to improve the articular and cutaneous manifestations
of psoriatic arthritis (PsA). In this study, we further evaluated the safety, efficacy, and effect …
of psoriatic arthritis (PsA). In this study, we further evaluated the safety, efficacy, and effect …
Intraarticular injection of anakinra in osteoarthritis of the knee: a multicenter, randomized, double‐blind, placebo‐controlled study
…, P Goupille, AD Beaulieu, FX Burch… - Arthritis Care & …, 2009 - Wiley Online Library
Objective To evaluate the clinical response, safety, and tolerability of a single intraarticular
injection of anakinra in patients with symptomatic osteoarthritis (OA) of the knee. Methods …
injection of anakinra in patients with symptomatic osteoarthritis (OA) of the knee. Methods …
Around-the-clock, controlled-release oxycodone therapy for osteoarthritis-related pain: placebo-controlled trial and long-term evaluation
SH Roth, RM Fleischmann, FX Burch… - Archives of Internal …, 2000 - jamanetwork.com
… Dr Burch is in private practice in San Antonio, and Dr Bockow is in private practice in
Seattle, Wash. Dr Roth is now with ArthroCare, Arthritis Care & Research, PC, Phoenix. Dr …
Seattle, Wash. Dr Roth is now with ArthroCare, Arthritis Care & Research, PC, Phoenix. Dr …
[HTML][HTML] A randomized, double-blind study of AMG 108 (a fully human monoclonal antibody to IL-1R1) in patients with osteoarthritis of the knee
SB Cohen, S Proudman, AJ Kivitz, FX Burch… - Arthritis research & …, 2011 - Springer
Introduction AMG 108 is a fully human, immunoglobulin subclass G2 (IgG2) monoclonal
antibody that binds the human interleukin-1 (IL-1) receptor type 1, inhibiting the activity of IL-1a …
antibody that binds the human interleukin-1 (IL-1) receptor type 1, inhibiting the activity of IL-1a …
Continued inhibition of radiographic progression in patients with psoriatic arthritis following 2 years of treatment with etanercept.
PJ Mease, AJ Kivitz, FX Burch, EL Siegel… - The Journal of …, 2006 - jrheum.org
OBJECTIVE: Clinical and radiographic responses were evaluated in patients with psoriatic
arthritis (PsA) treated for up to 2 years with etanercept. METHODS: Patients were previously …
arthritis (PsA) treated for up to 2 years with etanercept. METHODS: Patients were previously …
Safety, tolerability, and clinical outcomes after intraarticular injection of a recombinant adeno-associated vector containing a tumor necrosis factor antagonist gene …
…, KH Dao, CH Pritchard, DN Fiske, FX Burch… - The Journal of …, 2010 - jrheum.org
Objective. To assess safety and clinical outcomes in patients with inflammatory arthritis after
intraarticular (IA) injection of rAAV2-TNFR:Fc, a recombinant adeno-associated viral vector …
intraarticular (IA) injection of rAAV2-TNFR:Fc, a recombinant adeno-associated viral vector …
Safety of tacrolimus in patients with rheumatoid arthritis: long-term experience
DE Yocum, DE Furst, WG Bensen, FX Burch… - …, 2004 - academic.oup.com
Objective. To evaluate the long-term safety of tacrolimus 3 mg/day in patients with rheumatoid
arthritis (RA). Methods. Patients with active RA who had discontinued all DMARDs for at …
arthritis (RA). Methods. Patients with active RA who had discontinued all DMARDs for at …
[HTML][HTML] Evaluating the benefits of patterned stimulation in the treatment of osteoarthritis of the knee: a multi-center, randomized, single-blind, controlled study with an …
FX Burch, JN Tarro, JJ Greenberg, WJ Carroll - Osteoarthritis and Cartilage, 2008 - Elsevier
OBJECTIVE: This study investigated the benefits of the combination of interferential (IF) and
patterned muscle stimulation in the treatment of osteoarthritis (OA) of the knee. DESIGN: …
patterned muscle stimulation in the treatment of osteoarthritis (OA) of the knee. DESIGN: …
A placebo-controlled, randomized, double-blinded study evaluating the safety of etanercept in patients with rheumatoid arthritis and concomitant comorbid diseases
MH Weisman, HE Paulus, FX Burch, AJ Kivitz, J Fierer… - 2007 - academic.oup.com
… For this study, Dr Baumgartner, Dr Burch and Dr Kivitz received research support from Amgen,
Mr Kerr served as a consultant for Amgen and Dr Paulus, Dr Fierer and Dr Weisman were …
Mr Kerr served as a consultant for Amgen and Dr Paulus, Dr Fierer and Dr Weisman were …
A hypocomplementemic vasculitic urticarial syndrome: report of four new cases and definition of the disease
CR Zeiss, FX Burch, RJ Marder, NL Furey… - The American journal of …, 1980 - Elsevier
We describe four new patients with a unique syndrome of persistent urticaria, with leukoclastic
angiitis, severe angioedema, occasional life-threatening laryngeal edema, arthritis, …
angiitis, severe angioedema, occasional life-threatening laryngeal edema, arthritis, …